Metabolic fate of pitavastatin, a new inhibitor of HMG-CoA reductase: human UDP-glucuronosyltransferase enzymes involved in lactonization (Q44273082)

1 December 2017

Metabolic fate of pitavastatin, a new inhibitor of HMG-CoA reductase: human UDP-glucuronosyltransferase enzymes involved in lactonization (English)

1 reference

1 December 2017

Fujino H

1

1 reference

1 December 2017

Yamada I

2

1 reference

1 December 2017

Shimada S

3

1 reference

1 December 2017

Yoneda M

4

1 reference

1 December 2017

Kojima J

5

1 reference

1 December 2017

language of work or name

English

0 references

publication date

1 January 2003

1 reference

1 December 2017

1 reference

1 December 2017

33

1 reference

1 December 2017

27-41

1 reference

1 December 2017

1

1 reference

Lovastatin and simvastatin--inhibitors of HMG CoA reductase and cholesterol biosynthesis

1 December 2017

1 reference

https://api.crossref.org/works/10.1080%2F0049825021000017957

Lipid lowering and plaque regression. New insights into prevention of plaque disruption and clinical events in coronary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0049825021000017957

Specificity of human UDP-glucuronosyltransferases and xenobiotic glucuronidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0049825021000017957

Metabolism and drug interactions of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in transplant patients: are the statins mechanistically similar?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0049825021000017957

Properties of acyl glucuronides: implications for studies of the pharmacokinetics and metabolism of acidic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0049825021000017957

NK-104: a novel synthetic HMG-CoA reductase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0049825021000017957

Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0049825021000017957

Human UDP-glucuronosyltransferases: metabolism, expression, and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0049825021000017957

Effects of NK-104, a new hydroxymethylglutaryl-coenzyme reductase inhibitor, on low-density lipoprotein cholesterol in heterozygous familial hypercholesterolemia. Hokuriku NK-104 Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0049825021000017957

The interconversion kinetics, equilibrium, and solubilities of the lactone and hydroxyacid forms of the HMG-CoA reductase inhibitor, CI-981

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0049825021000017957

Identification of metabolites of NK-104, an HMG-CoA reductase inhibitor, in rat, rabbit and dog bile

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0049825021000017957

Simultaneous determination of NK-104 and its lactone in biological samples by column-switching high-performance liquid chromatography with ultraviolet detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0049825021000017957

Disposition and metabolism of pravastatin sodium in rats, dogs and monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0049825021000017957

Assessment of microsomal tolbutamide hydroxylation by a simple thin-layer chromatography radioactivity assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0049825021000017957

Hypolipidemic effect of NK-104, a potent HMG-CoA reductase inhibitor, in guinea pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F0049825021000017957

10.1080/0049825021000017957

21 January 2018

Identifiers

DOI

1 reference

1 December 2017

1 reference